Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Olfactory Bulb | 18 | 2021 | 50 | 5.280 |
Why?
|
| Endocannabinoids | 8 | 2024 | 40 | 2.960 |
Why?
|
| Smell | 8 | 2021 | 38 | 2.230 |
Why?
|
| Neurons | 17 | 2021 | 1246 | 2.020 |
Why?
|
| Olfaction Disorders | 4 | 2024 | 10 | 1.890 |
Why?
|
| Olfactory Pathways | 7 | 2013 | 14 | 1.450 |
Why?
|
| Cannabinoids | 4 | 2024 | 67 | 1.350 |
Why?
|
| Synaptic Transmission | 10 | 2018 | 156 | 1.280 |
Why?
|
| Oils, Volatile | 2 | 2020 | 13 | 1.210 |
Why?
|
| Neuronal Plasticity | 5 | 2021 | 126 | 1.110 |
Why?
|
| Receptor, Cannabinoid, CB1 | 4 | 2024 | 40 | 1.090 |
Why?
|
| Signal Transduction | 6 | 2020 | 2111 | 1.030 |
Why?
|
| Analgesics | 2 | 2018 | 55 | 1.000 |
Why?
|
| Interneurons | 5 | 2019 | 64 | 0.950 |
Why?
|
| Brain | 5 | 2018 | 1452 | 0.910 |
Why?
|
| Receptors, Metabotropic Glutamate | 6 | 2009 | 27 | 0.910 |
Why?
|
| Receptors, GABA-A | 4 | 2018 | 65 | 0.900 |
Why?
|
| Regeneration | 1 | 2024 | 29 | 0.880 |
Why?
|
| Receptors, Cannabinoid | 2 | 2015 | 27 | 0.860 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2019 | 81 | 0.840 |
Why?
|
| Wound Healing | 1 | 2024 | 82 | 0.840 |
Why?
|
| Animals | 38 | 2024 | 16695 | 0.830 |
Why?
|
| Neurodegenerative Diseases | 2 | 2021 | 138 | 0.780 |
Why?
|
| Patch-Clamp Techniques | 12 | 2019 | 228 | 0.750 |
Why?
|
| Ageusia | 1 | 2021 | 2 | 0.730 |
Why?
|
| Visual Pathways | 1 | 2021 | 40 | 0.700 |
Why?
|
| Brachial Artery | 1 | 2021 | 27 | 0.700 |
Why?
|
| Olfactory Receptor Neurons | 3 | 2013 | 29 | 0.690 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 274 | 0.690 |
Why?
|
| Visual Perception | 1 | 2021 | 75 | 0.680 |
Why?
|
| Manduca | 5 | 2004 | 9 | 0.670 |
Why?
|
| Energy Intake | 1 | 2021 | 162 | 0.650 |
Why?
|
| Body Composition | 1 | 2021 | 160 | 0.650 |
Why?
|
| Terpenes | 1 | 2020 | 29 | 0.640 |
Why?
|
| Cannabis | 2 | 2018 | 90 | 0.610 |
Why?
|
| Pheromones | 4 | 2000 | 18 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 1804 | 0.600 |
Why?
|
| Marijuana Abuse | 2 | 2018 | 93 | 0.570 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 69 | 0.570 |
Why?
|
| Anti-Anxiety Agents | 1 | 2018 | 17 | 0.570 |
Why?
|
| Exercise | 2 | 2021 | 674 | 0.560 |
Why?
|
| Sodium Channels | 1 | 2018 | 66 | 0.560 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 76 | 0.540 |
Why?
|
| Humans | 27 | 2024 | 42163 | 0.520 |
Why?
|
| Synapses | 6 | 2012 | 184 | 0.510 |
Why?
|
| Sodium Channel Blockers | 2 | 2017 | 18 | 0.500 |
Why?
|
| Nerve Net | 3 | 2013 | 96 | 0.480 |
Why?
|
| Anticonvulsants | 2 | 2018 | 39 | 0.480 |
Why?
|
| Eugenol | 1 | 2015 | 6 | 0.470 |
Why?
|
| Anesthetics | 1 | 2015 | 11 | 0.460 |
Why?
|
| Pain | 1 | 2018 | 283 | 0.460 |
Why?
|
| Bufanolides | 1 | 2014 | 2 | 0.460 |
Why?
|
| Action Potentials | 8 | 2017 | 246 | 0.420 |
Why?
|
| Prosencephalon | 1 | 2013 | 34 | 0.410 |
Why?
|
| Resistance Training | 2 | 2023 | 20 | 0.410 |
Why?
|
| Neuroprotective Agents | 2 | 2018 | 267 | 0.400 |
Why?
|
| Blood Pressure | 3 | 2021 | 662 | 0.390 |
Why?
|
| Mice | 12 | 2024 | 6490 | 0.380 |
Why?
|
| Amygdala | 4 | 2000 | 125 | 0.380 |
Why?
|
| Neural Inhibition | 4 | 2008 | 48 | 0.370 |
Why?
|
| Male | 26 | 2024 | 22779 | 0.360 |
Why?
|
| Panax | 1 | 2011 | 6 | 0.360 |
Why?
|
| Ginsenosides | 1 | 2011 | 4 | 0.360 |
Why?
|
| GABA Modulators | 1 | 2010 | 1 | 0.350 |
Why?
|
| Glutamic Acid | 2 | 2011 | 131 | 0.350 |
Why?
|
| Anxiety | 1 | 2018 | 847 | 0.330 |
Why?
|
| Retina | 2 | 2024 | 288 | 0.330 |
Why?
|
| Membrane Potentials | 7 | 2014 | 221 | 0.320 |
Why?
|
| Olfactory Nerve | 4 | 2009 | 7 | 0.310 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2018 | 1112 | 0.300 |
Why?
|
| Electric Stimulation | 6 | 2013 | 198 | 0.290 |
Why?
|
| Motor Activity | 1 | 2011 | 438 | 0.290 |
Why?
|
| Sense Organs | 2 | 1998 | 11 | 0.290 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 2007 | 16 | 0.290 |
Why?
|
| Neural Pathways | 2 | 2006 | 139 | 0.280 |
Why?
|
| Mice, Knockout | 4 | 2024 | 1010 | 0.270 |
Why?
|
| Piperidines | 3 | 2018 | 80 | 0.270 |
Why?
|
| Excitatory Postsynaptic Potentials | 7 | 2011 | 80 | 0.260 |
Why?
|
| Biotin | 2 | 2017 | 24 | 0.260 |
Why?
|
| Sex Attractants | 2 | 2008 | 4 | 0.240 |
Why?
|
| Excitatory Amino Acid Antagonists | 4 | 2012 | 93 | 0.240 |
Why?
|
| Optics and Photonics | 1 | 2005 | 43 | 0.240 |
Why?
|
| Organ Culture Techniques | 5 | 2011 | 102 | 0.240 |
Why?
|
| Respiratory Muscles | 2 | 2023 | 10 | 0.230 |
Why?
|
| Salivation | 1 | 2024 | 1 | 0.230 |
Why?
|
| Cricetulus | 2 | 2015 | 82 | 0.230 |
Why?
|
| CHO Cells | 2 | 2015 | 123 | 0.230 |
Why?
|
| Electrophysiology | 5 | 2007 | 138 | 0.230 |
Why?
|
| Circadian Rhythm | 2 | 2024 | 234 | 0.220 |
Why?
|
| Cricetinae | 2 | 2015 | 241 | 0.220 |
Why?
|
| Female | 18 | 2024 | 24018 | 0.220 |
Why?
|
| Natural Language Processing | 1 | 2024 | 21 | 0.210 |
Why?
|
| Exercise Tolerance | 1 | 2023 | 22 | 0.210 |
Why?
|
| Insulin-Secreting Cells | 1 | 2023 | 28 | 0.200 |
Why?
|
| Evoked Potentials | 3 | 2001 | 90 | 0.190 |
Why?
|
| Rats | 9 | 2013 | 3701 | 0.190 |
Why?
|
| Dementia | 1 | 2023 | 155 | 0.180 |
Why?
|
| Breathing Exercises | 1 | 2021 | 1 | 0.180 |
Why?
|
| Inhalation | 1 | 2021 | 8 | 0.180 |
Why?
|
| Taste Disorders | 1 | 2020 | 2 | 0.170 |
Why?
|
| Somatosensory Disorders | 1 | 2020 | 2 | 0.170 |
Why?
|
| Absorptiometry, Photon | 1 | 2021 | 74 | 0.170 |
Why?
|
| Neurons, Afferent | 2 | 2006 | 44 | 0.170 |
Why?
|
| Olfactory Mucosa | 1 | 2020 | 19 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2013 | 1737 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 101 | 0.160 |
Why?
|
| Serotonin | 1 | 2000 | 125 | 0.160 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 261 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 67 | 0.150 |
Why?
|
| Adenosine | 1 | 1999 | 62 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 81 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 86 | 0.150 |
Why?
|
| Skin | 1 | 2020 | 185 | 0.150 |
Why?
|
| Indans | 1 | 2018 | 14 | 0.140 |
Why?
|
| Nitric Oxide | 1 | 2021 | 381 | 0.140 |
Why?
|
| Heart Rate | 1 | 2019 | 261 | 0.140 |
Why?
|
| Quinine | 1 | 2017 | 12 | 0.140 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2017 | 13 | 0.140 |
Why?
|
| Benzamides | 1 | 2018 | 78 | 0.140 |
Why?
|
| Caspase 3 | 1 | 2018 | 226 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2017 | 38 | 0.130 |
Why?
|
| Hippocampus | 2 | 2013 | 591 | 0.130 |
Why?
|
| Aging | 1 | 2021 | 764 | 0.120 |
Why?
|
| Ethanol | 1 | 2018 | 221 | 0.120 |
Why?
|
| Aged | 6 | 2024 | 7982 | 0.120 |
Why?
|
| Gene Expression | 1 | 2018 | 692 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2021 | 990 | 0.120 |
Why?
|
| GABA Antagonists | 3 | 2006 | 29 | 0.110 |
Why?
|
| Amphibian Venoms | 1 | 2014 | 1 | 0.110 |
Why?
|
| Ouabain | 1 | 2014 | 15 | 0.110 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 28 | 0.110 |
Why?
|
| Ion Channel Gating | 1 | 2014 | 81 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 39 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2019 | 467 | 0.110 |
Why?
|
| Hypertension | 1 | 2021 | 823 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 972 | 0.110 |
Why?
|
| Time Factors | 5 | 2021 | 1848 | 0.110 |
Why?
|
| Scopolamine | 1 | 2013 | 5 | 0.100 |
Why?
|
| Muscarinic Antagonists | 1 | 2013 | 11 | 0.100 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 11 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2014 | 150 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 24 | 0.100 |
Why?
|
| Muscle Strength | 2 | 2023 | 36 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2013 | 64 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 13458 | 0.100 |
Why?
|
| Suprachiasmatic Nucleus | 2 | 2024 | 44 | 0.100 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2012 | 6 | 0.100 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2012 | 15 | 0.100 |
Why?
|
| Middle Aged | 6 | 2024 | 11819 | 0.100 |
Why?
|
| Arachidonic Acids | 1 | 2012 | 25 | 0.090 |
Why?
|
| Naphthalenes | 1 | 2012 | 38 | 0.090 |
Why?
|
| Benzoxazines | 1 | 2012 | 46 | 0.090 |
Why?
|
| Morpholines | 1 | 2012 | 73 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 126 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2012 | 93 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2023 | 305 | 0.090 |
Why?
|
| Rats, Long-Evans | 3 | 2000 | 108 | 0.090 |
Why?
|
| Astrocytes | 1 | 2013 | 244 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 382 | 0.090 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 27 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 825 | 0.080 |
Why?
|
| Thalamus | 2 | 2000 | 34 | 0.080 |
Why?
|
| Cell Count | 2 | 2013 | 140 | 0.080 |
Why?
|
| Sex Characteristics | 2 | 2024 | 253 | 0.080 |
Why?
|
| Dendrites | 1 | 2009 | 57 | 0.080 |
Why?
|
| Alkadienes | 2 | 2008 | 6 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2000 | 303 | 0.070 |
Why?
|
| Protein Binding | 1 | 2010 | 1076 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 45 | 0.060 |
Why?
|
| Photolysis | 1 | 2005 | 25 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 649 | 0.060 |
Why?
|
| United States | 1 | 2015 | 5072 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 39 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2004 | 37 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2004 | 102 | 0.050 |
Why?
|
| Aldehydes | 1 | 2004 | 69 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3077 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 223 | 0.050 |
Why?
|
| Respiratory Therapy | 1 | 2023 | 3 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 295 | 0.050 |
Why?
|
| DNA | 1 | 2007 | 594 | 0.050 |
Why?
|
| Muscles | 1 | 2023 | 84 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2023 | 76 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 86 | 0.050 |
Why?
|
| Hand Strength | 1 | 2023 | 39 | 0.050 |
Why?
|
| Base Sequence | 1 | 2004 | 997 | 0.050 |
Why?
|
| Tetrodotoxin | 2 | 2017 | 23 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2001 | 13 | 0.050 |
Why?
|
| Colorado | 1 | 2021 | 16 | 0.040 |
Why?
|
| Young Adult | 2 | 2024 | 4936 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2001 | 110 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 242 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1020 | 0.040 |
Why?
|
| Receptors, GABA | 1 | 2000 | 28 | 0.040 |
Why?
|
| Taste | 1 | 2020 | 45 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 324 | 0.040 |
Why?
|
| Nervous System | 1 | 2000 | 33 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2000 | 37 | 0.040 |
Why?
|
| Xanthines | 1 | 1999 | 1 | 0.040 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1999 | 6 | 0.040 |
Why?
|
| Bicuculline | 1 | 1999 | 18 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2000 | 133 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 37 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2023 | 393 | 0.040 |
Why?
|
| Oscillometry | 1 | 1998 | 9 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 47 | 0.040 |
Why?
|
| Chemoreceptor Cells | 1 | 1998 | 19 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 850 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 2018 | 42 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 24 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2017 | 34 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2017 | 30 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2017 | 49 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 189 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 88 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2018 | 134 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 487 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 1617 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 130 | 0.030 |
Why?
|
| Mental Processes | 1 | 1996 | 16 | 0.030 |
Why?
|
| Invertebrates | 1 | 1996 | 15 | 0.030 |
Why?
|
| Vertebrates | 1 | 1996 | 33 | 0.030 |
Why?
|
| Brain Mapping | 1 | 1996 | 132 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 1416 | 0.030 |
Why?
|
| Receptors, GABA-B | 2 | 2006 | 11 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 34 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 2598 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2008 | 21 | 0.020 |
Why?
|
| Lepidoptera | 1 | 2008 | 10 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 182 | 0.020 |
Why?
|
| Tacrine | 1 | 2006 | 1 | 0.020 |
Why?
|
| Xanthenes | 1 | 2006 | 12 | 0.020 |
Why?
|
| Benzoates | 1 | 2006 | 17 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2006 | 51 | 0.020 |
Why?
|
| Glycine | 1 | 2006 | 47 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2006 | 83 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 150 | 0.010 |
Why?
|
| Cell Shape | 1 | 2005 | 42 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 207 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 658 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2001 | 34 | 0.010 |
Why?
|
| Phosphinic Acids | 1 | 2000 | 3 | 0.010 |
Why?
|
| Propanolamines | 1 | 2000 | 13 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 2000 | 43 | 0.010 |
Why?
|
| Receptors, Glycine | 1 | 2000 | 3 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2000 | 58 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2000 | 144 | 0.010 |
Why?
|